---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010600"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2024-03-20T23:59:59+00:00"
generated_at: "2026-06-04T11:23:50.399586+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Harrow gets CMS confirmation that IHEEZO is separately payable in physician office setting

## Summary
- CMS confirmed IHEEZO's J-Code 2403 will be included in April 2024 quarterly ASP drug pricing file.
- Separate payment for IHEEZO in physician offices applies under Medicare Part B beginning April 2024.
- This regulatory milestone may improve IHEEZO adoption and reimbursement for Harrow (HROW).

## SEC filing metadata
- accession: 0001493152-24-010600
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2024-03-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/0001493152-24-010600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010600
- JSON: https://secwatch.observer/filing/0001493152-24-010600.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.